Literature DB >> 14978139

Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient.

Birgitte F Lausen1, Lotte Hougs, Lone Schejbel, Carsten Heilmann, Torben Barington.   

Abstract

The bone marrow is an important source of Abs involved in long-term protection from recurrence of infections. Allogenic bone marrow transplantation (BMT) fails to restore this working memory. Attempts to overcome this immunodeficiency by immunization of the donor have not been very successful. More needs to be known about transfer of B cell memory by BMT. We tracked memory B cells from the donor to the recipient during BMT of a girl with leukocyte adhesion deficiency. Vaccination of her HLA-identical sibling donor 7 days before harvest induced Haemophilus influenzae type b (Hib) capsular polysaccharide (HibCP)-specific B cells readily detectable in marrow and blood. BMT did not lead to spontaneous production of HibCP Abs, but the recipient responded well to booster immunizations 9 and 11 mo after BMT. HibCP-specific B cells were obtained 7 days after the vaccinations, and their V(H) genes were sequenced and analyzed for rearrangements and unique patterns of somatic hypermutations identifying clonally related cells. Ninety (74%) of 121 sequences were derived from only 16 precursors. Twelve clones were identified in the donor, and representatives from all of them were detected in the recipient where they constituted 61 and 68% of the responding B cells after the first and second vaccinations, respectively. No evidence for re-entry of memory clones into the process of somatic hypermutation was seen in the recipient. Thus, memory B cells were transferred from the donor, persisted for at least 9 mo in the recipient, and constituted the major part of the HibCP-specific repertoire.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978139     DOI: 10.4049/jimmunol.172.5.3305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

Authors:  Aprille Seidel; David Smith; Edward Yung; Lia Aquino; Tumul Srivastava; Vinod Pullarkat; Ricardo Spielberger; Stephen J Forman; Don J Diamond
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-08       Impact factor: 5.742

2.  Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency.

Authors:  Lone Schejbel; Hanne Marquart; Vagn Andersen; Henrik Permin; Pernille Andersen; Arne Svejgaard; Torben Barington
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

Review 3.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 4.  B cells and transplantation: an educational resource.

Authors:  Trudy N Small; William H Robinson; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

5.  B cells establish, but do not maintain, long-lived murine anti-peanut IgE(a).

Authors:  D M Moutsoglou; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2016-04       Impact factor: 5.018

6.  Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; P A W te Boekhorst; R ten Cate; N M Wulffraat; R Q Hintzen; J M Vossen; M J D van Tol
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

7.  Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

Authors:  David M Burns; Rose Tierney; Claire Shannon-Lowe; Jo Croudace; Charlotte Inman; Ben Abbotts; Sandeep Nagra; Christopher P Fox; Sridhar Chaganti; Charles F Craddock; Paul Moss; Alan B Rickinson; Martin Rowe; Andrew I Bell
Journal:  Blood       Date:  2015-10-08       Impact factor: 25.476

Review 8.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

9.  Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Angela Mensen; Christoph Ochs; Andrea Stroux; Friedrich Wittenbecher; Martin Szyska; Luisa Imberti; Simon Fillatreau; Lutz Uharek; Renate Arnold; Bernd Dörken; Andreas Thiel; Carmen Scheibenbogen; Il-Kang Na
Journal:  J Transl Med       Date:  2013-08-14       Impact factor: 5.531

10.  Transmission of lupus anticoagulant by allogeneic stem cell transplantation.

Authors:  Mira Romany Massoud; Basem M William; Katrina Harrill; Brenda Wimpfheimer Cooper; Marcos de Lima; Alvin H Schmaier
Journal:  Rev Bras Hematol Hemoter       Date:  2014-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.